Literature DB >> 28712818

Systemic lupus erythematosus and thyroid disease - Experience in a single medical center in Taiwan.

Yu-Chuan Liu1, Wen-Ya Lin1, Ming-Chin Tsai1, Lin-Shien Fu2.   

Abstract

BACKGROUND: To investigate the association of systemic lupus erythematosus (SLE) with thyroid diseases in a medical center in central Taiwan.
METHODS: This is a retrospective cohort of 2796 SLE patients in a tertiary referral medical center from 2000 to 2013. We screened SLE by catastrophic illness registration from national insurance bureau; and thyroid diseases by ICD 9 codes, then confirmed by thyroid function test, auto-antibody, medical and/or surgical intervention. We compared the rate of hyperthyroidism, hypothyroidism and autoimmune thyroid disease (AITD) in SLE patients and the 11,184 match controls. We calculated the rate of these thyroid diseases and positive antibodies to thyroglobulin (ATGAb), thyroid peroxidase (TPOAb) in SLE patients grouped by the presence of overlap syndrome and anti-dsDNA antibody. We also compared the association of thyroid diseases to severe SLE conditions, including renal, central nervous system (CNS) involvement, and thrombocytopenia.
RESULTS: Compared to the matched controls, the cumulative incidence of thyroid disease, including hyperthyroidism, hypothyroidism and AITD, were all higher in SLE patients (p < 0.0001). The average age of SLE patients with thyroid diseases patients were older than those without thyroid diseases (p = 0.002). Those had euthyroid AITD were younger than other patients with thyroid diseases (p = 0.02). Up to 30.3% SLE patients had overlap syndrome and had higher relative risk of thyroid diseases than those without overlap syndrome, in terms of hypothyroidism and AITD, but not hyperthyroidism. SLE patients with thyroid diseases also carry higher risk for severe complications such as renal involvement (p = 0.024) central nervous system involvement (p < 0.0001).
CONCLUSION: SLE patients had significantly higher rate of hyperthyroidism, hypothyroidism, and AITD than the matched control. Among lupus patients, the risks of thyroid diseases are even higher in the presence of overlap syndrome. SLE patients with thyroid diseases had higher risk of renal and CNS involvement.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  AITD; CNS involvement; Hyperthyroidism; Hypothyroidism; Overlap syndrome; Renal involvement; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2017        PMID: 28712818     DOI: 10.1016/j.jmii.2016.11.008

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.

Authors:  Cheng-Yu Lin; Ya-Ting Cheng; Ming-Ling Chang; Rong-Nan Chien
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

2.  Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism.

Authors:  Ting Huang; Jiarong Li; Weiru Zhang
Journal:  BMC Med Res Methodol       Date:  2020-05-01       Impact factor: 4.615

3.  Co-Occurrence of Systemic Lupus Erythematosus and Autoimmune Polyendocrine Syndrome II: Is There a Pathologic Link?

Authors:  Sameen Aamer; Salman Akram; Muhammad Ali Butt; Aimal Shah
Journal:  Cureus       Date:  2020-10-26

4.  Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism.

Authors:  Jiajia Ni; Jingyi Li; Yuyao Wang; Liying Guan; Haiyan Lin; Li Zhang; Haiqing Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

5.  Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis.

Authors:  Qian Li; Bin Wang; Kaida Mu; Jing Zhang; Yanping Yang; Wei Yao; Jie Zhu; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-11       Impact factor: 5.555

6.  Dysregulated thyroid hormones correlate with anxiety and depression risk in patients with autoimmune disease.

Authors:  Xiaorong Wu; Kaikai Zhang; Yulong Xing; Wei Zhou; Yanqiu Shao; Guizheng Li; Qing Rui
Journal:  J Clin Lab Anal       Date:  2020-11-18       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.